Specifically, samples were considered as CDX2-positive if 50% or more of the cancer cells displayed widespread nuclear CDX2 expression, whereas samples were considered as CDX2-negative if less than 50% of the cancer cells showed nuclear CDX2 expression. The gene discussed is CDX2; the disease is cancer.